Tokyo, April 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061238) titled 'Exploratory study on the safety of yogurt ingestion and glycemic variability using FreeStyle Libre 2 in patients with type 2 diabetes' on April 13.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - No treatment
Primary Sponsor:
Institute - THE PHAGE, Inc.
Condition:
Condition - Type 2 diabetes
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to investigate the safety and the effects on glycemic variability of long-term (12-week) ingestion of yogurt in patients with type 2 diabetes receiving standard treatment (metformin). Utilizing the FreeStyle Libre 2 system and a dietary management app, we will exploratorily evaluate effects such as the suppression of postprandial glucose spikes, while confirming safety aspects including the risk of hypoglycemia and the impact on hepatic and renal functions under concomitant use of metformin.
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Yogurt:Yes
Interventions/Control_2 - Yogurt:No
Eligibility:
Age-lower limit - 35
years-old
<
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Japanese patients with type 2 diabetes aged 35 years or older (regardless of sex).
2.Patients taking metformin (including combination drugs).
3.Patients with HbA1c < 8.0%.
4.Patients who own a smartphone.
Key exclusion criteria - 1.Women who are pregnant, breastfeeding, or may be pregnant.
2.Patients with severe hepatic or renal diseases.
3.Patients with a milk allergy.
4.Patients who are judged to have difficulty maintaining compliance during the study period.
5.Patients using implantable medical devices such as pacemakers.
6.Patients who plan to remove the FreeStyle Libre 2 sensor during the study period (e.g., for health checkups).
Target Size - 40
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 19 Day
Date of IRB - 2026 Year 03 Month 29 Day
Anticipated trial start date - 2026 Year 04 Month 14 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070066
Disclaimer: Curated by HT Syndication.